Yufa Li

1.7k total citations · 2 hit papers
42 papers, 1.3k citations indexed

About

Yufa Li is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Yufa Li has authored 42 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 8 papers in Epidemiology. Recurrent topics in Yufa Li's work include Lung Cancer Treatments and Mutations (10 papers), MRI in cancer diagnosis (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Yufa Li is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), MRI in cancer diagnosis (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Yufa Li collaborates with scholars based in China, United States and Ethiopia. Yufa Li's co-authors include Li‐Xu Yan, Zhong‐Yi Dong, Yi‐Long Wu, Qing Zhou, Wen‐Zhao Zhong, Zhi Xie, Hai‐Yan Tu, Jian Su, Si‐Yang Maggie Liu and Chong‐Rui Xu and has published in prestigious journals such as Advanced Energy Materials, Polymer and European Journal of Cancer.

In The Last Decade

Yufa Li

39 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer

2017 333 citations Zhong‐Yi Dong, Jia‐Tao Zhang et al. OncoImmunology profile →
Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study

2023 110 citations Junwei Su, Yufa Li et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yufa Li China	16	694	530	289	226	175	42	1.3k
Haitang Yang China	25	638 0.9×	849 1.6×	622 2.2×	225 1.0×	74 0.4×	82	1.6k
Roberto Pazo-Cid Spain	17	801 1.2×	553 1.0×	331 1.1×	335 1.5×	78 0.4×	69	1.4k
Tatsuya Manabe Japan	18	544 0.8×	157 0.3×	245 0.8×	153 0.7×	98 0.6×	63	1.0k
Anna J. Żaczek Poland	23	739 1.1×	219 0.4×	693 2.4×	528 2.3×	177 1.0×	86	1.6k
Shoichiro Ohtani Japan	19	939 1.4×	399 0.8×	371 1.3×	375 1.7×	64 0.4×	92	1.4k
Eunsung Jun South Korea	20	619 0.9×	236 0.4×	331 1.1×	196 0.9×	65 0.4×	71	1.1k
Anna Wilkins United Kingdom	16	640 0.9×	400 0.8×	340 1.2×	140 0.6×	136 0.8×	39	1.3k
Donglai Chen China	21	294 0.4×	867 1.6×	366 1.3×	249 1.1×	198 1.1×	80	1.5k
Jung-Woo Choi South Korea	15	318 0.5×	158 0.3×	337 1.2×	203 0.9×	126 0.7×	31	1.2k
Magnus T. Dillon United Kingdom	15	700 1.0×	271 0.5×	534 1.8×	152 0.7×	110 0.6×	23	1.3k

Countries citing papers authored by Yufa Li

Since Specialization

Citations

This map shows the geographic impact of Yufa Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yufa Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yufa Li more than expected).

Fields of papers citing papers by Yufa Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yufa Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yufa Li. The network helps show where Yufa Li may publish in the future.

Co-authorship network of co-authors of Yufa Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yufa Li. A scholar is included among the top collaborators of Yufa Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yufa Li. Yufa Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shi, Yanying, Yudi Wang, Wenrui Li, et al.. (2025). Boosting Spiro‐OMeTAD Doping via Structurally Asymmetrical Nanohorns for High‐Performance Carbon‐Based Perovskite Solar Cells. Advanced Energy Materials. 15(25). 1 indexed citations

Shi, Jin, Junwei Su, Chengzhi Zhou, et al.. (2024). Triple-targeted therapy of dabrafenib, trametinib, and osimertinib for the treatment of the acquired BRAF V600E mutation after progression on EGFR-tyrosine kinase inhibitors in advanced EGFR-mutated non-small cell lung cancer patients. Translational Lung Cancer Research. 13(10). 2538–2548.

Xiao, Fa-Man, Yuqing Chen, Yufa Li, et al.. (2023). Pathological characteristics and tumour immune microenvironment of lung malignancies with RET rearrangement. Cancer Treatment and Research Communications. 35. 100707–100707.

Zhang, Shiling, Chanyuan Zhang, Yuqing Chen, et al.. (2023). Expression of EGFR-mutant proteins and genomic evolution in EGFR-mutant transformed small cell lung cancer. Journal of Thoracic Disease. 15(9). 4620–4635. 5 indexed citations

Xiao, Wei, et al.. (2021). Enrichment of Wee1/CDC2 and NF-κB Signaling Pathway Constituents Mutually Contributes to CDDP Resistance in Human Osteosarcoma. Cancer Research and Treatment. 54(1). 277–293. 9 indexed citations

Chen, Yuqing, Yufa Li, Chanyuan Zhang, et al.. (2021). Response to Icotinib Plus Chemotherapy in Pulmonary Atypical Carcinoid Harboring the EGFR L858R Mutation: A Brief Report. JTO Clinical and Research Reports. 2(12). 100258–100258. 4 indexed citations

Chen, Dan, Yihui Jiang, Yufa Li, et al.. (2020). In situ TiB2/Cu composites fabricated by spray deposition using solid−liquid and liquid−liquid reactions. Transactions of Nonferrous Metals Society of China. 30(7). 1849–1856. 15 indexed citations

Li, Ruiqi, Lijia Liu, Jingfeng Wang, et al.. (2018). Supramolecular chirality control via self-assembly of oligoaniline in the chemical oxidative polymerization process. New Journal of Chemistry. 42(20). 16766–16773. 7 indexed citations

Su, Shan, Zhong‐Yi Dong, Zhi Xie, et al.. (2018). Strong Programmed Death Ligand 1 Expression Predicts Poor Response and De Novo Resistance to EGFR Tyrosine Kinase Inhibitors Among NSCLC Patients With EGFR Mutation. Journal of Thoracic Oncology. 13(11). 1668–1675. 101 indexed citations

10.

Zhang, Ming, Wei Zhao, Yufa Li, et al.. (2018). VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma. BMC Cancer. 18(1). 511–511. 76 indexed citations

11.

Liu, Si‐Yang Maggie, Zhong‐Yi Dong, Si-Pei Wu, et al.. (2018). Clinical relevance of PD-L1 expression and CD8+ T cells infiltration in patients with EGFR-mutated and ALK-rearranged lung cancer. Lung Cancer. 125. 86–92. 56 indexed citations

12.

Hu, Genwen, et al.. (2018). Intravoxel Incoherent Motion and Arterial Spin Labeling MRI Analysis of Reversible Unilateral Ureteral Obstruction in Rats. Journal of Magnetic Resonance Imaging. 50(1). 288–296. 13 indexed citations

13.

Dong, Zhong‐Yi, Chao Zhang, Yufa Li, et al.. (2017). Genetic and Immune Profiles of Solid Predominant Lung Adenocarcinoma Reveal Potential Immunotherapeutic Strategies. Journal of Thoracic Oncology. 13(1). 85–96. 47 indexed citations

14.

Dong, Zhong‐Yi, Jia‐Tao Zhang, Si‐Yang Maggie Liu, et al.. (2017). EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer. OncoImmunology. 6(11). e1356145–e1356145. 333 indexed citations breakdown →

15.

Wu, Shaojie, Yufa Li, & Yujue Wang. (2016). [Expression of asparagine synthetase in relapsed or refractory extranodal NK/T cell lymphoma].. Europe PMC (PubMed Central). 37(4). 465–469. 1 indexed citations

16.

Li, Jinchao, et al.. (2016). A Research on Structure Optimization of Engine Mount Bracket Based on Misuse Working Condition. 38(10). 1226. 1 indexed citations

17.

Jiang, Shanshan, Hao Yu, Xianlong Wang, et al.. (2015). Molecular MRI differentiation between primary central nervous system lymphomas and high-grade gliomas using endogenous protein-based amide proton transfer MR imaging at 3 Tesla. European Radiology. 26(1). 64–71. 91 indexed citations

18.

Xiao, Fa-Man, Yifeng Bai, Zhenzhu Chen, et al.. (2014). Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100. European Journal of Cancer. 50(8). 1541–1554. 100 indexed citations

19.

Hu, Genwen, Queenie Chan, Xianyue Quan, et al.. (2014). Intravoxel incoherent motion MRI evaluation for the staging of liver fibrosis in a rat model. Journal of Magnetic Resonance Imaging. 42(2). 331–339. 26 indexed citations

20.

Guan, Jian, Yufa Li, Yong‐Jian Deng, et al.. (2011). FMNL2 is a positive regulator of cell motility and metastasis in colorectal carcinoma. The Journal of Pathology. 224(3). 377–388. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact